ESCI期刊Regenerative Engineering and Translational Medicine 2024/2025影响因子:2.215 (REGEN ENG TRANSL MED) (2364-4133). (ENGI

显示全部楼层 · 发表于 2025-3-25 04:08:31

Submitted on: 09 December 2010. Revised on: 14 January 2011. Accepted on: 10 February 2011. NULL

显示全部楼层 · 发表于 2025-3-25 09:40:20

显示全部楼层 · 发表于 2025-3-25 12:18:51

Submitted on: 26 September 2017. Revised on: 30 October 2017. Accepted on: 06 November 2017. Regenerative Engineering and Translational Medicine

显示全部楼层 · 发表于 2025-3-25 18:52:46

Submitted on: 31 July 2004. Revised on: 30 August 2004. Accepted on: 26 September 2004. NULL

显示全部楼层 · 发表于 2025-3-25 23:03:48

Submitted on: 06 January 2021. Revised on: 18 January 2021. Accepted on: 04 February 2021. Regenerative Engineering and Translational Medicine

显示全部楼层 · 发表于 2025-3-26 01:58:59

Submitted on: 02 November 2022. Revised on: 15 December 2022. Accepted on: 23 December 2022. Regenerative Engineering and Translational Medicine

显示全部楼层 · 发表于 2025-3-26 04:35:22

显示全部楼层 · 发表于 2025-3-26 09:54:07

Submitted on: 01 April 2007. Revised on: 09 May 2007. Accepted on: 31 May 2007. Regenerative Engineering and Translational Medicine

显示全部楼层 · 发表于 2025-3-26 13:32:18

Submitted on: 07 July 2013. Revised on: 29 July 2013. Accepted on: 23 August 2013. NULL

显示全部楼层 · 发表于 2025-3-26 20:01:45

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 09:45
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved